跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
西力欣 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Cefuroxime Axetil Tablets
Approved
化学药品
Cefuroxime Axetil Tablets
GlaxoSmithKline AG
🇨🇳 National Medical Products Administration
Approval Date
Nov 16, 2022
Approval ID
ba19ce130181f9b8
Company
GlaxoSmithKline AG
Type
化学药品
Approval Details
Approval Id
ba19ce130181f9b8
Approval Number
国药准字HJ20181025
Generic Name
头孢呋辛酯片
Generic Name En
Cefuroxime Axetil Tablets
Trade Name
西力欣
Drug Type
化学药品
Dosage Form
片剂
Strength
0.25g
Reg Date
2022-11-16
Expired Date
2027-11-15
Company Name
GlaxoSmithKline AG
Production Company Name
GLAXO OPERATIONS UK LIMITED
Company Detail Path
/organization/glaxosmithkline-ag
Production Company Detail Path
/organization/glaxo-operations-uk-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 16, 2022
Approval ID
ba19ce130181f9b8
Type
化学药品
Back to NMPA Approvals